Acetylcysteine for prevention of contrast nephropathy: meta-analysis
- 1 August 2003
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 362 (9384), 598-603
- https://doi.org/10.1016/s0140-6736(03)14189-x
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Contrast nephropathy or contrast creatininopathyClinical Cardiology, 2003
- A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiographyKidney International, 2002
- Systematic reviews in health care: Investigating and dealing with publication and other biases in meta-analysisBMJ, 2001
- The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiencyJournal of the American College of Cardiology, 2000
- Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?The Lancet, 1998
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Reduced activity of antioxidant enzymes underlies contrast media-induced renal injury in volume depletionKidney International, 1992
- Contrast Material-Induced Renal Failure in Patients with Diabetes Mellitus, Renal Insufficiency, or BothNew England Journal of Medicine, 1989
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Hospital-acquired renal insufficiency: A prospective studyAmerican Journal Of Medicine, 1983